Medical Technology

Wed, 19/04/2017 - 07:30
Edinburgh, UK, 19th April 2017 / Sciad Newswire / Synpromics Ltd, the leading synthetic promoter and gene control company
Mon, 10/04/2017 - 10:00
Expansion is Supported by four Broad Patents for Company’s Leap-In Transposase® Technology
Thu, 16/03/2017 - 07:30
Edinburgh, UK, 16th March 2017 / Sciad Newswire / Synpromics Ltd, the leading synthetic promoter and gene control company
Tue, 28/02/2017 - 12:00
Hamburg, Germany, 27th February 2017 / Sciad Newswire / GAIA AG, a global pioneer in digital therapy, announced today that
Tue, 14/02/2017 - 07:30
London, UK, 14th February 2017 / Sciad Newswire / Biosys UK Limited (“Biosys” or the “Company
Thu, 09/02/2017 - 07:30
Epsom, UK, 9th February 2017 / Sciad Newswire / Now is the time for healthcare innovators to adopt plastic electronics and revolutionise healthcare monitoring and
Thu, 09/02/2017 - 07:30
Epsom, UK, 9th February 2017 / Sciad Newswire / Now is the time for the consumer electronics industry to adopt plastic electronics as new devices are set to revol
Mon, 06/02/2017 - 07:30
Medherant Ltd., a University of Warwick spin-out developing a novel transdermal drug delivery patch technology, is pleased to announce the appointment of Dr Ken Cunningham as Chair. Dr Cunningham joins Medherant as the company prepares to move into clinical studies with its leading TEPI Patch® technology.
Wed, 04/01/2017 - 07:30
Edinburgh, UK, 4th January 2017 / Sciad Newswire / Synpromics Ltd, the leading synthetic promoter and gene control compan
Wed, 04/01/2017 - 07:00
Prokarium and Probiomed today announced the start of their collaboration to scale-up the manufacture of orally administered vaccines in a formulation that would enable stability at 40°C for several weeks. The first vaccine to be manufactured will be developed to prevent so-called ‘Montezuma’s revenge’ or diarrhoea, which affects the local population as well travellers in Mexico and many countries.

Pages